These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9469371)

  • 1. 1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology.
    J Clin Oncol; 1998 Feb; 16(2):793-5. PubMed ID: 9469371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology.
    Bast RC; Ravdin P; Hayes DF; Bates S; Fritsche H; Jessup JM; Kemeny N; Locker GY; Mennel RG; Somerfield MR;
    J Clin Oncol; 2001 Mar; 19(6):1865-78. PubMed ID: 11251019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology.
    J Clin Oncol; 1996 Oct; 14(10):2843-77. PubMed ID: 8874347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines.
    Smith TJ; Davidson NE; Schapira DV; Grunfeld E; Muss HB; Vogel VG; Somerfield MR
    J Clin Oncol; 1999 Mar; 17(3):1080-2. PubMed ID: 10071303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology.
    Desch CE; Benson AB; Smith TJ; Flynn PJ; Krause C; Loprinzi CL; Minsky BD; Petrelli NJ; Pfister DG; Somerfield MR
    J Clin Oncol; 1999 Apr; 17(4):1312. PubMed ID: 10561194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommended breast cancer surveillance guidelines. American Society of Clinical Oncology.
    J Clin Oncol; 1997 May; 15(5):2149-56. PubMed ID: 9164230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.
    J Clin Oncol; 1997 Aug; 15(8):2996-3018. PubMed ID: 9256144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.
    Harris L; Fritsche H; Mennel R; Norton L; Ravdin P; Taube S; Somerfield MR; Hayes DF; Bast RC;
    J Clin Oncol; 2007 Nov; 25(33):5287-312. PubMed ID: 17954709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
    Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
    Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene.
    Chlebowski RT; Collyar DE; Somerfield MR; Pfister DG
    J Clin Oncol; 1999 Jun; 17(6):1939-55. PubMed ID: 10561236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel.
    Hillner BE; Ingle JN; Berenson JR; Janjan NA; Albain KS; Lipton A; Yee G; Biermann JS; Chlebowski RT; Pfister DG
    J Clin Oncol; 2000 Mar; 18(6):1378-91. PubMed ID: 10715310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology.
    Recht A; Edge SB; Solin LJ; Robinson DS; Estabrook A; Fine RE; Fleming GF; Formenti S; Hudis C; Kirshner JJ; Krause DA; Kuske RR; Langer AS; Sledge GW; Whelan TJ; Pfister DG;
    J Clin Oncol; 2001 Mar; 19(5):1539-69. PubMed ID: 11230499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition.
    Chlebowski RT; Col N; Winer EP; Collyar DE; Cummings SR; Vogel VG; Burstein HJ; Eisen A; Lipkus I; Pfister DG;
    J Clin Oncol; 2002 Aug; 20(15):3328-43. PubMed ID: 12149307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Standards, options and recommendations for tumor markers in colorectal cancer].
    Eche N; Pichon MF; Quillien V; Gory-Delabaere G; Riedinger JM; Basuyau JP; Daver A; Buecher B; Conroy T; Dieu L; Bidart JM; Deneux L;
    Bull Cancer; 2001 Dec; 88(12):1177-206. PubMed ID: 11792611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.
    Locker GY; Hamilton S; Harris J; Jessup JM; Kemeny N; Macdonald JS; Somerfield MR; Hayes DF; Bast RC;
    J Clin Oncol; 2006 Nov; 24(33):5313-27. PubMed ID: 17060676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
    Sturgeon CM; Duffy MJ; Stenman UH; Lilja H; Brünner N; Chan DW; Babaian R; Bast RC; Dowell B; Esteva FJ; Haglund C; Harbeck N; Hayes DF; Holten-Andersen M; Klee GG; Lamerz R; Looijenga LH; Molina R; Nielsen HJ; Rittenhouse H; Semjonow A; Shih IeM; Sibley P; Sölétormos G; Stephan C; Sokoll L; Hoffman BR; Diamandis EP;
    Clin Chem; 2008 Dec; 54(12):e11-79. PubMed ID: 19042984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ASCO experience with evidence-based clinical practice guidelines.
    Smith TJ; Somerfield MR
    Oncology (Williston Park); 1997 Nov; 11(11A):223-7. PubMed ID: 9430192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology.
    Schiffer CA; Anderson KC; Bennett CL; Bernstein S; Elting LS; Goldsmith M; Goldstein M; Hume H; McCullough JJ; McIntyre RE; Powell BL; Rainey JM; Rowley SD; Rebulla P; Troner MB; Wagnon AH;
    J Clin Oncol; 2001 Mar; 19(5):1519-38. PubMed ID: 11230498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002.
    Winer EP; Hudis C; Burstein HJ; Chlebowski RT; Ingle JN; Edge SB; Mamounas EP; Gralow J; Goldstein LJ; Pritchard KI; Braun S; Cobleigh MA; Langer AS; Perotti J; Powles TJ; Whelan TJ; Browman GP
    J Clin Oncol; 2002 Aug; 20(15):3317-27. PubMed ID: 12149306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology.
    Sepulveda AR; Hamilton SR; Allegra CJ; Grody W; Cushman-Vokoun AM; Funkhouser WK; Kopetz SE; Lieu C; Lindor NM; Minsky BD; Monzon FA; Sargent DJ; Singh VM; Willis J; Clark J; Colasacco C; Rumble RB; Temple-Smolkin R; Ventura CB; Nowak JA
    J Clin Oncol; 2017 May; 35(13):1453-1486. PubMed ID: 28165299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.